We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 7.23%
2 Financials 5.58%
3 Industrials 4.98%
4 Consumer Discretionary 4.95%
5 Healthcare 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLNO
7251
DELISTED
Soleno Therapeutics
SLNO
$14K ﹤0.01%
+365
New +$14.4K
TMQ
7252
Trilogy Metals
TMQ
$665M
$14K ﹤0.01%
14,935
-7,964
-35% -$7.87K
AIFC
7253
AI Financial Corp
AIFC
$57.3M
$14K ﹤0.01%
2,716
+494
+22% +$2.4K
ENSV
7254
DELISTED
Enservco Corp.
ENSV
$14K ﹤0.01%
+1,783
New +$10.8K
CTHR
7255
DELISTED
Charles & Colvard Ltd
CTHR
$14K ﹤0.01%
+1,663
New +$14.6K
AEY
7256
DELISTED
ADDvantage Technologies Group
AEY
$14K ﹤0.01%
+1,046
New +$15.6K
INFI
7257
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$14K ﹤0.01%
10,590
-6,614
-38% -$8.21K
ARQL
7258
DELISTED
Arqule Inc
ARQL
$14K ﹤0.01%
+12,891
New +$14.8K
NIHD
7259
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$14K ﹤0.01%
31,207
+4,504
+17% +$2.65K
BLRX
7260
BioLineRX
BLRX
$11.7M
$13K ﹤0.01%
+19
New +$11.8K
PERI icon
7261
Perion Network
PERI
$383M
$13K ﹤0.01%
3,642
-6,837
-65% -$28.8K
DYSL
7262
DELISTED
Dynasil Corporation of America
DYSL
$13K ﹤0.01%
+10,784
New +$13.2K
CRVP
7263
DELISTED
Crystal Rock Holdings, Inc.
CRVP
$13K ﹤0.01%
19,251
+5,199
+37% +$4.06K
EYPT icon
7264
PUT
EyePoint Inc
EYPT
$1.18B
$12K ﹤0.01%
1,020
-1,930
-65% -$24.6K
IGC icon
7265
IGC Pharma
IGC
$30.8M
$12K ﹤0.01%
32,404
+8,628
+36% +$3.2K
PERI icon
7266
PUT
Perion Network
PERI
$383M
$12K ﹤0.01%
3,467
+34
+1% +$143
TROO icon
7267
TROOPS Inc
TROO
$231M
$12K ﹤0.01%
+11,050
New +$12.1K
XTIA icon
7268
XTI Aerospace
XTIA
$60.4M
0
HBM.WS
7269
DELISTED
Hudbay Minerals Inc.
HBM.WS
$12K ﹤0.01%
43,108
+4,815
+13% +$1.77K
PGH
7270
DELISTED
Pengrowth Energy Corporation
PGH
$12K ﹤0.01%
11,283
-44,054
-80% -$31.8K
AMPE
7271
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$11K ﹤0.01%
61
-79
-56% -$12.5K
GMO
7272
DELISTED
General Moly, Inc.
GMO
$11K ﹤0.01%
29,044
-2,617
-8% -$1.11K
SCON
7273
DELISTED
Superconductor Technologies Inc.
SCON
$11K ﹤0.01%
+102
New +$12.6K
SLS icon
7274
SELLAS Life Sciences
SLS
$2.49B
$10K ﹤0.01%
19
-43
-69% -$28.4K
AXN
7275
DELISTED
Aoxing Pharmaceutical Company Inc.
AXN
$10K ﹤0.01%
+61,329
New +$16.7K

Similar funds

Ken Griffin's Q3 2017 Portfolio in Review

As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.4% a quarter earlier, followed by Financials and Industrials.

  • Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.